SPEGRA TABLETS

Name: SPEGRA TABLETS
Brand: Ingram Biosciences Pvt. Ltd.
Price: 2562.0 INR
Availability: InStock

Price 2562.0 INR/ Piece

Get a Price/Quote

MOQ : 2 Pieces

SPEGRA TABLETS Specification

Salt Composition
DOLUTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE TABLETS

Dosage Form
ONCE-A-DAY

Origin of Medicine
INDIA

Pacakaging (Quantity Per Box)
30

Indication
HIV

Drug Type
Other

Ingredients
Spegra is a brand-name, combination antiretroviral medication used to treat human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents. It is a once-daily, single-tablet regimen that combines three active ingredients to prevent the virus from multiplying in the body. Active ingredients and mechanism of action The three active components in Spegra work synergistically to inhibit different stages of the HIV replication cycle: Dolutegravir (50 mg): This is an integrase strand transfer inhibitor (INSTI). It blocks the integrase enzyme, which HIV needs to integrate its genetic material into human cells. Emtricitabine (200 mg): A nucleoside reverse transcriptase inhibitor (NRTI), this drug prevents the viral RNA from being converted into DNA by inhibiting the reverse transcriptase enzyme. Tenofovir Alafenamide (TAF) (25 mg): This is a nucleotide reverse transcriptase inhibitor (NtRTI) that also blocks the reverse transcriptase enzyme. TAF is a newer formulation of tenofovir with better kidney and bone safety profiles compared to older versions. Key benefits and uses Controls HIV-1 infection: Spegra helps suppress the viral load, control the infection, and improve the immune system's function. Simplifies treatment: As a single tablet taken once daily, it improves treatment adherence and makes managing the condition easier for patients. Improves quality of life: By reducing HIV-related complications, the medication helps improve the lifespan and overall quality of life for individuals with HIV. Important considerations Not a cure for HIV/AIDS: While effective at controlling the virus, Spegra does not cure HIV or AIDS. Medical supervision required: The medication should be taken exactly as prescribed by a healthcare provider. Stopping treatment abruptly can lead to drug resistance. Regular monitoring: To monitor the patient's condition and the medication's effect on the body, doctors may recommend regular blood tests to check kidney and liver function. Common side effects: Potential side effects include insomnia, fatigue, headache, nausea, and diarrhea. Warnings and precautions: Patients with pre-existing kidney or liver disease should use the medication with caution. It is also important to avoid alcohol consumption and to discuss usage with a doctor if pregnant or breastfeeding.

Physical Form
Tablets

Function
Other

Dosage
ONCE-A-DAY

Dosage Guidelines
AS PER DIOCTOR ADVICE

Suitable For
Women, Adults, Aged Person

Quantity
1 Pieces

Storage Instructions
ROOM TEMPERATURE

SPEGRA TABLETS Trade Information

Minimum Order Quantity
2 Pieces

FOB Port
NEW DELHI

Payment Terms
Cash Advance (CA), Cash in Advance (CID)

Supply Ability
500 Pieces Per Day

Delivery Time
3 Days

Sample Available
No

Sample Policy
Contact us for information regarding our sample policy

Packaging Details
1*30

Main Export Market(s)
Asia

Main Domestic Market
All India

About SPEGRA TABLETS

Spegra isa brand-name, combination antiretroviral medication used to treat human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents. It is a once-daily, single-tablet regimen that combines three active ingredients to prevent the virus from multiplying in the body.

Active ingredients and mechanism of action

The three active components in Spegra work synergistically to inhibit different stages of the HIV replication cycle:

Dolutegravir (50 mg):This is an integrase strand transfer inhibitor (INSTI). It blocks the integrase enzyme, which HIV needs to integrate its genetic material into human cells.
Emtricitabine (200 mg):A nucleoside reverse transcriptase inhibitor (NRTI), this drug prevents the viral RNA from being converted into DNA by inhibiting the reverse transcriptase enzyme.
Tenofovir Alafenamide (TAF) (25 mg):This is a nucleotide reverse transcriptase inhibitor (NtRTI) that also blocks the reverse transcriptase enzyme. TAF is a newer formulation of tenofovir with better kidney and bone safety profiles compared to older versions.

Key benefits and uses

Controls HIV-1 infection:Spegra helps suppress the viral load, control the infection, and improve the immune system's function.
Simplifies treatment:As a single tablet taken once daily, it improves treatment adherence and makes managing the condition easier for patients.
Improves quality of life:By reducing HIV-related complications, the medication helps improve the lifespan and overall quality of life for individuals with HIV.

Important considerations

Not a cure for HIV/AIDS:While effective at controlling the virus, Spegra does not cure HIV or AIDS.
Medical supervision required:The medication should be taken exactly as prescribed by a healthcare provider. Stopping treatment abruptly can lead to drug resistance.
Regular monitoring:To monitor the patient's condition and the medication's effect on the body, doctors may recommend regular blood tests to check kidney and liver function.
Common side effects:Potential side effects include insomnia, fatigue, headache, nausea, and diarrhea.
Warnings and precautions:Patients with pre-existing kidney or liver disease should use the medication with caution. It is also important to avoid alcohol consumption and to discuss usage with a doctor if pregnant or breastfeeding.